Use of protease inhibitors and non-nucleoside reverse transcriptase inhibitors among medicaid beneficiaries with AIDS

American Journal of Public Health

Volumn 91, Issue 9, 2001, Pages 1474-1481

  Sambamoorthi, U ^a   Moynihan, P J ^a   McSpiritt, E ^a   Crystal, S ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; DEMOGRAPHY; ETHNIC GROUP; FEMALE; HEALTH INSURANCE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID;

EID: 0034869971     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.91.9.1474     Document Type: Article

References (37)

1. Racial differences in the use of drug therapy for HIV disease in an urban community
2. Differences in access to zidovudine (AZT) among symptomatic HIV-infected persons
3. Access and use of medications in HIV disease
4. Implications of generalists' slow adoption of zidovudine in clinical practice
5. The diffusion of innovation in AIDS treatment: Zidovudine use in two New Jersey cohorts
6. Barriers to use of free antiretroviral therapy in injection drug users
7. Socioeconomic differences in the use of HIV combination antiretroviral therapy
8. Declining morbidity mortality among patients with advanced human immunodeficiency virus infection
9. Variations in the care of HIV-infected adults in the United States: Results from the HIV Cost and Services Utilization Study
10. Protease inhibitor use among a community sample of people with HIV disease
11. Use of protease inhibitors among persons with AIDS in Los Angeles County
12. Protease inhibitor-based therapy is associated with decreased HIV-related health care costs in men treated at a Veterans Administration hospital
13. The use of health services by women with HIV infection
14. Zidovudine the natural history of the acquired immunodeficiency syndrome
15. Patterns of Medicaid expenditures after AIDS diagnosis
16. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy
17. Profile of Medicare beneficiaries with AIDS: Application of an AIDS casefinding algorithm
18. Medicaid 2176 home and community-based care waivers: The first 10 years
19. New Jersey's Medicaid waiver for acquired immunodeficiency syndrome
20. Racial variation in cardiac procedure use and survival following acute myocardial infarction in the Department of Veterans Affairs
21. Racial differences in the use of invasive cardiovascular procedures in the Department of Veterans Affairs medical system
22. Racial and ethnic disparities in the use of cardiovascular procedures: Associations with types of health insurance
23. Effects of race and income on mortality and use of services among Medicare beneficiaries
24. Nonclinical factors associated with surgery received for treatment of early-stage breast cancer
25. The influence of race on the use of surgical procedures for treatment of peripheral vascular disease of the lower extremities
26. HIV/AIDS patients' perspectives on adhering to regimens containing protease inhibitors
27. Delays in protease inhibitor use in clinical practice
28. Adherence to guidelines for antiretroviral therapy and for preventing opportunistic infections in HIV-infected adults adolescents in Ryan White-funded facilities in the United States
29. Division of AIDS Prevention and Control begins broad initiative to decrease perinatal transmission
30. Medicaid policies for the physicians' services provided to Medicaid recipients with AIDS
31. Transitions in insurance and employment among people with HIV infection
32. Monitoring the quality of Medicaid managed care
33. Prevalence predictors of highly active antiretroviral therapy use in persons with HIV infection in the US